Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Details for Australian Patent Application No. 2009322269 (hide)

Owner Abbott Laboratories

Inventors Bruncko, Milan; Dai, Yujia; Ding, Hong; Doherty, George A.; Elmore, Steven W.; Hasvold, Lisa; Hexamer, Laura; Kunzer, Aaron R.; Mantei, Robert A.; McClellan, William J.; Park, Chang H.; Park, Cheol-Min; Petros, Andrew M.; Song, Xiaohong; Souers, Andrew J.; Sullivan, Gerard M.; Tao, Zhi-Fu; Wang, Gary T.; Wang, Le; Wang, Xilu; Wendt, Michael D.

Agent Spruson & Ferguson

Pub. Number AU-A-2009322269

PCT Pub. Number WO2010/065824

Priority 61/119,844 04.12.08 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065824 Priority application(s): WO2010/065824

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322270-Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer

2009322260-Mini-hepcidin peptides and methods of using thereof